The Canadian Early Arthritis Cohort (CATCH): Patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity

Journal of Rheumatology

Volumn 39, Issue 11, 2012, Pages 2071-2080

  Bykerk, Vivian P ^a,b   Jamal, Shahin ^c   Boire, Gilles ^d   Hitchon, Carol A ^e   Haraoui, Boulos ^f   Pope, Janet E ^g   Thorne, J Carter ^h   Sun, Ye ^a   Keystone, Edward C ⁱ  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f NOTRE DAME HOSPITAL   (Canada)

^g ST JOSEPH S HEALTH CENTRE   (Canada)

^h Southlake Regional Health Care   (Canada)

ⁱ Pediatric Oral and Maxillofacial Surgery   (Canada)

Author keywords

Classification; Cohort study; Criteria; Early diagnosis; Patient outcomes; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ETANERCEPT; GOLIMUMAB; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; BONE EROSION; CANADA; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT RADIOGRAPHY; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; METACARPOPHALANGEAL JOINT; MONOTHERAPY; MORNING STIFFNESS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROXIMAL INTERPHALANGEAL JOINT; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; CANADA; COHORT STUDIES; EUROPE; FEMALE; FINGER JOINT; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; SYNOVITIS; UNITED STATES;

EID: 84868369271     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120029     Document Type: Conference Paper

References (39)

1. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 1999;42:415-20.
2. Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, et al. The PREMIER study. A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37.
3. Goekoop-Ruiterman YP, Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
4. Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:27-35.
5. St. Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum 2004;50:3432-43.
6. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
7. Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: Aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-9.
8. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004;364:263-9.
9. Bykerk VP, Baron M, Boire G, Haraoui B, Khraishi M, LeClercq S, et al. Canadian consensus statement on early optimal therapy in early rheumatoid arthritis. J Can Rheumatol Assoc 2004;14:11-3.
10. Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2012;39:1559-82.
11. Mjaavatten MD, Uhlig T, Haugen AJ, Nygaard H, Sidenvall G, Helgetveit K, et al. Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: Results from the NOR-VEAC cohort. Arthritis Res Ther 2009;11:R146.
12. Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: Results from the Norfolk Arthritis Register. Br J Rheumatol 1994;33:735-9.
13. Symmons DP, Silman AJ. The Norfolk Arthritis Register (NOAR). Clin Exp Rheumatol 2003;21:S94-9.
14. Claessen SJ, Hazes JM, Huisman MA, van Zeben D, Luime JJ, Weel AE. Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial. BMC Musculoskelet Disord 2009;10:71.
15. Jansen LM, van Schaardenburg D, van der Horst-Bruinsma IE, Bezemer PD, Dijkmans BA. Predictors of functional status in patients with early rheumatoid arthritis. Ann Rheum Dis 2000;59:223-6.
16. Jansen LM, van Schaardenburg D, van der Horst-Bruinsma IE, Dijkmans BA. One year outcome of undifferentiated polyarthritis. Ann Rheum Dis 2002;61:700-3.
17. van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003;21:S100-5.
18. Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria. Arthritis Rheum 2010;62:2569-81.
19. Bosello S, Fedele AL, Peluso G, Gremese E, Tolusso B, Ferraccioli G. Very early rheumatoid arthritis is the major predictor of major outcomes: Clinical ACR remission and radiographic non-progression. Ann Rheum Dis 2011;70:1292-5.
20. Lukas C, Combe B, Ravaud P, Sibilia J, Landewe R, van der Heijde D. Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Etude et Suivi des polyarthrites indifferenciees recentes [study and followup of early undifferentiated polyarthritis]. Arthritis Rheum 2011;63:1804-11.
21. Cader MZ, Filer A, Hazlehurst J, de Pablo P, Buckley CD, Raza K. Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: Comparison with 1987 ACR criteria in a very early synovitis cohort. Ann Rheum Dis 2011;70:949-55.
22. Walji S, Baron M, Boire G, Hitchon C, Bykerk V. Early arthritis in Canada: Data from the Clearer Group. J Rheumatol 2006;33:c55.
23. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011;63:573-86.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA. A self-administered Rheumatoid Arthritis Disease Activity Index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995;38:795-8.
26. Rohekar G, Pope J. Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis. J Rheumatol 2009;36:2178-82.
27. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: The Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982;9:789-93.
28. Blevins L, McDonald CJ. Fisher's exact test: An easy-to-use statistical test for comparing outcomes. MD Comput 1985; 2:15-9, 68.
29. Meur NL, Gentleman R. Analyzing biological data using R: Methods for graphs and networks. Methods Mol Biol 2012;804:343-73.
30. Fransen J, Creemers MC, van Riel PL. Remission in rheumatoid arthritis: Agreement of the Disease Activity Score (DAS28) with the ARA preliminary remission criteria. Rheumatology 2004;43:1252-5.
31. Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005;23:S93-9.
32. Statistics Canada. Population by year, by province by territory. Statistics Canada 2010 September 29. [Internet. Accessed June 12, 2012.] Available from: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/ demo02d-eng.htm
33. Kremer J. The CORRONA database. Ann Rheum Dis 2005;64:iv37-iv41.
34. Khanna D, Oh M, Furst DE, Ranganath V, Gold RH, Sharp JT, et al. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort. Arthritis Rheum 2007;57:440-7.
35. Kuriya B, Sun Y, Boire G, Haraoui B, Hitchon C, Pope JE, et al. Remission in early rheumatoid arthritis - A comparison of new ACR/EULAR remission criteria to established criteria. J Rheumatol 2012;39:1155-8.
36. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: Evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290-7.
37. Zeidler H. The need to better classify and diagnose early and very early rheumatoid arthritis. J Rheumatol 2012;39:212-7.
38. Soubrier M, Lukas C, Sibilia J, Fautrel B, Roux F, Gossec L, et al. Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: Data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis 2011; 70:611-5.
39. Forslind K, Hafstrom I, Ahlmen M, Svensson B. Sex: A major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 2007;66:46-52.